Point Of Care (POC) Diagnostics Market Size, Share | Industry Report 2025

The global Point of Care (POC) diagnostics market was valued at $18.54 Billion in 2017 and is forecast to grow at a modestxx.3 % CAGR between 2018 and 2025, culminating in 2025 global sales of $32.7 Billion.

Point of Care (POC) Diagnostics tests are achieved through transportable, portable, and handheld instruments and test kits. The overall goal is to collect the specimen and obtain the result close to the patient location so that treatment can be fast and accurate. We are observing the usage of Point of Care (POC) in home INR testing, accident scene blood gas/electrolyte, emergency department HIV testing. Clinical Laboratory Improvement Amendments (CLIA) will bring regulation and streamline usage of Point of Care (POC) Diagnostics tests. This will attribute to increased adoption of Point of Care (POC) Diagnostics tests.

Ease of waived testing requirements by both CLIA and Joint Commission and market attractiveness will drive Point of Care (POC) Diagnostics tests. Care process optimization, patient outcome, and disaster recovery are some of the factors will further drive the usage of Care (POC) Diagnostics tests.

We have segmented the Point of Care (POC) Diagnostics market by diagnostic type into Glucose Monitoring, Infectious Disease, Pregnancy and Fertility, Hematology Testing, Cardiometabolic Monitoring, Coagulation Monitoring, Urinalysis Testing, Tumor Markers, Cholesterol Test Strips, Drugs Abuse Testing, Fecal Occult Testing. Some of the benefits of Point of Care (POC) Diagnostics will be Portability, convenience, speed, connectivity, sample quality and quality assurance. While selecting these kits, sample size need and time to run the test are deciding factor.

We are observing a greater adaptation of Point of Care (POC) Diagnostics for glucose monitoring, pregnancy and fertility. However, diagnostics for tumor markers, drugs abuse testing and hematology testing will be in demand during the forecast period.

Click the link below to view the report description:
www.ameriresearch.com/product/point-of-care-poc-diagnostics-market-size/

Key findings from the study: -

• We have segmented the Point of Care (POC) Diagnostics market by diagnostic type into Glucose Monitoring, Infectious Disease, Pregnancy and Fertility, Hematology Testing, Cardiometabolic Monitoring, Coagulation Monitoring, Urinalysis Testing, Tumor Markers, Cholesterol Test Strips, Drugs Abuse Testing, Fecal Occult Testing.

• The key market participants include Siemens Healthineers, Abaxis, F. Hoffmann-La Roche Ltd, BioMérieux SA, QIAGEN, Danaher, Abbott (Alere), Instrumentation Laboratory, Nova Biomedical, Trividia Health Inc., OraSure Technologies Inc, Quidel Corporation, Sekisui Diagnostics LLC, Trinity Biotech, Johnson & Johnson and Becton Dickinson & Company (BD).

Ameri Research has segmented the Point Of Care (POC) Diagnostics Market by material categories, product type, end-use and region:

Market Segmentation:

Point of Care (POC) diagnostics market by Diagnostics Type (Revenue, Million, 2014 – 2025)

• Glucose Monitoring
• Infectious Disease
• Pregnancy and Fertility
• Hematology Testing
• Cardiometabolic Monitoring
• Coagulation Monitoring
• Urinalysis Testing
• Tumor Markers
• Cholesterol Test Strips
• Drugs Abuse Testing
• Fecal Occult Testing

Point of Care (POC) diagnostics market by End-Use(Revenue, Million, 2014 – 2025)

• Clinics
• Hospitals
• Home
• Laboratories
• Others

Point of Care (POC) diagnostics market Regional Outlook (Revenue, USD Million, 2014- 2025)

• North America
o U.S.
o Canada
• Europe
o UK
o Germany
o France
o Italy
o Spain

• Asia Pacific
o Japan
o China
o India
o Australia

• Latin America
o Brazil
o Mexico
o Columbia

• Middle East and Africa
o South Africa
o Saudi Arabia

Browse Full Report @ www.ameriresearch.com/product/point-of-care-poc-diagnostics-market-size/

About Us:

Ameri Research Inc. (www.ameriresearch.com) is a U.S. based market research and consulting company, registered in the State of Florida and headquartered in Tampa Bay Area. At Ameri Research we are passionately curious about people, markets, brands and society. Our ability to gauge market movements, deep expertise in data science, strong domain expertise and years of collective global experiences helps us to bring unmatched quality in deliverables to our clients. With carefully planned systems and processes in place, we cater to the requirements of our clients in a timely and cost-efficient manner, bringing increased predictability to their business. Each year we are publishing more than 100 syndicated reports in healthcare, chemicals, materials, food & beverages, defense & aerospace, media & entertainment, sports & fitness, and energy. We offer our clients a unique depth of knowledge and expertise around-

Market Mapping
Opportunity Assessment
Positioning
Pricing Analysis
Market Entry Strategy
Competitive Intelligence
Program Evaluation
Performance Reporting
Data Analytics
Developing a culture of collaboration and curiosity, we attract the highest caliber of likeminded people having ability to influence and shape the future.

Follow us on LinkedIn for our latest upcoming reports www.linkedin.com/company/ameri-research-inc./
Follow us on Facebook for our latest upcoming reports www.facebook.com/AmeriResearchInc/
Follow us on Twitter for our latest upcoming reports www.twitter.com/AmeriResearch

Contact Us:

Ameri Research Inc.
6816 Muncaster Ct,
Tampa, FL 33625
United States.
Tel: 1-813-666-0858
Email: Inquiry@ameriresearch.com
Web: www.ameriresearch.com

This release was published on openPR.